. Author manuscript; available in PMC: 2012 Dec 1.

Published in final edited form as: Lupus. 2011 Oct 5;20(14):1526–1534. doi: 10.1177/0961203311420317

Table 2.

Cardiovascular risk estimates in women with SLE and female controls

Cardiovascular risk scores	Controls (n=65)			SLE (n=121)			P- value^*
Cardiovascular risk scores	Median risk (IQR)	<10% risk n (%)	≥10% risk n (%)	Median risk (IQR)	<10% risk n (%)	≥10% risk n (%)	P- value^*

10 year Framingham risk (%)	0 (0–1)	63 (97%)	2 (3%)	0 (0–1)	120 (99%)	1 (1%)	0.245
10 year Framingham coronary age-modified risk (%)	0 (0–0)	63 (97%)	2 (3%)	0 (0–0)	111 (92%)	10 (8%)	0.170
10 year Reynolds risk (%)	0.3 (0.1–0.9)	64 (98.5%)	1 (1.5%)	0.3 (0.1–0.9)	119 (98%)	2 (2%)	0.953
10 year Reynolds coronary age-modified risk (%)	0.3 (0.1–0.5)	64 (98.5%)	1 (1.5%)	0.3 (0.1–0.8)	115 (95%)	6 (5%)	0.243

Data are presented as median and interquartile range (IQR) for 10-year risk.

Pearson Chi-square test was used to compare the proportions of subjects with risk <10% and ≥10% in SLE vs. Controls